ANZAN 2021 Conference Review

In this review:

Cancer therapy neurology update
Marginal structural modelling finds natalizumab confers a superior reduction in relapse in MS
Gut microbiota and nutritional profiles of Parkinson’s disease patients
Neurophobia: A study of Australian medical students and junior doctors
Nitrous oxide induced myeloneuropathy
Brain aging and cardiovascular risk factors in chronic HIV: A longitudinal MRI study
EEG use for low yield indications by non-neurologists not supported
Low rate of serious infections following long-term ocrelizumab therapy for MS
Reducing stroke treatment delays in Australia
The Victorian home subcutaneous immunoglobulin treatment program

Please login below to download this issue (PDF)